Expression of Fas/FasL and c-myc in bladder cancer and their correlation with tumor immune function
暂无分享,去创建一个
Wenyan Sun | Jian Li | Y. Shan | Yibin Zhou | Jiajun Zhang | Changyuan Dai | Qingwen Li
[1] Y. Murakami,et al. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium , 2015, Cell Death and Disease.
[2] M. Hahne,et al. Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky? , 2015, Cytokine.
[3] H. Kaplan,et al. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent , 2015, Journal of Neuroinflammation.
[4] P. Viriyavejakul,et al. Enhanced expression of Fas and FasL modulates apoptosis in the lungs of severe P. falciparum malaria patients with pulmonary edema. , 2015, International journal of clinical and experimental pathology.
[5] Qiang Zhang,et al. Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer. , 2015, American journal of cancer research.
[6] W. Gmeiner,et al. Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway. , 2015, Leukemia research.
[7] S. Thorne,et al. Splenectomy Promotes Indirect Elimination of Intraocular Tumors by CD8+ T Cells That Is Associated with IFNγ- and Fas/FasL-Dependent Activation of Intratumoral Macrophages , 2014, Cancer Immunology Research.
[8] F. Papachristou,et al. The Effects of Apigenin on the Expression of Fas/FasL Apoptotic Pathway in Warm Liver Ischemia-Reperfusion Injury in Rats , 2014, BioMed research international.
[9] W. Tan,et al. Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population , 2013, PloS one.
[10] A. Martínez-Ruíz,et al. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. , 2011, Gastroenterology.
[11] A. Bergeron,et al. Toll-like receptors in normal and malignant human bladders. , 2011, The Journal of urology.
[12] Mo-lin Li,et al. Antitumor effects of recombinant human Interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis , 2010, Cancer Chemotherapy and Pharmacology.
[13] Alimuddin Zumla,et al. Expression of apoptosis‐related genes in an Ethiopian cohort study correlates with tuberculosis clinical status , 2009, European journal of immunology.
[14] Anirban P. Mitra,et al. Molecular pathogenesis and diagnostics of bladder cancer. , 2009, Annual review of pathology.
[15] Gaosi Xu,et al. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells. , 2007, Cancer genetics and cytogenetics.
[16] Y. Lotan,et al. Soluble Fas—A promising novel urinary marker for the detection of recurrent superficial bladder cancer , 2006, Cancer.
[17] F. Shanahan,et al. Fas Ligand Promotes Tumor Immune Evasion of Colon Cancer In Vivo , 2006, Cell cycle.
[18] M. Schmitz,et al. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB , 1997, FEBS letters.
[19] R. Díaz-Peña,et al. [Genetics of ankylosing spondylitis]. , 2014, Revista medica de Chile.
[20] G. Parmiani,et al. Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.